UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

In another example, a US-managed care provider is using UiPath to tackle a backlog of more than 140,000 provider appeals.

UiPath has announced a series of developments including a $227.5 million share repurchase program and upcoming earnings release on September 4, 2025, with analysts projecting a doubling of earnings ...

UiPath aims to lead the RPA market by integrating advanced AI solutions, differentiating itself from competitors like Automation Anywhere and Blue Prism. Strategic partnerships with tech giants like ...

UiPath is showing accelerating revenue growth, improved margins, and raised guidance, signaling strong adoption of its agentic AI products. The company's ARR base at $1.72 billion already exceeds Wall ...

UiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...